Evogene (EVGN) Misses Q1 EPS by 2c

Evogene (NASDAQ: EVGN) reported Q1 EPS of ($0.21), $0.02 worse than the analyst estimate of ($0.19). Revenue for the quarter came in at $312 thousand versus the consensus estimate of $230.67 thousand.

For earnings history and earnings-related data on Evogene (EVGN) click here.

You May Also Be Interested In

• Evogene Chairman Nir Nimrodi to Join Quarterly Results Call to Address Current Dissident Shareholders Situation
• SanDisk upgraded at JPMorgan after investor day; shares climb
• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August